FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmaceutical industry and concerns compositions containing a fluoroquinolone antibiotic drug. The composition may be used as ear or nasal compositions, however it is best applicable as ophthalmic compositions.
EFFECT: compositions possess improved homogeneity, improved biological availability, less turbidity, either a combination of the given properties.
8 cl, 4 tbl, 2 dwg, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION AND METHOD OF PRODUCING EYE DROPS | 2014 |
|
RU2595837C2 |
| PHARMACEUTICAL COMPOSITIONS POSSESSING DESIRABLE BIOAVAILABILITY | 2009 |
|
RU2503453C2 |
| AEROSOL FLUOROCHINOLONES AND THEIR APPLICATIONS | 2006 |
|
RU2428986C2 |
| AEROSOLIZED FLUOROQUINOLONES AND USES THEREOF | 2006 |
|
RU2603638C2 |
| COMPOSITIONS CONTAINING ANTIBIOTIC AND CORTICOSTEROID | 2009 |
|
RU2496501C2 |
| AQUEOUS PHARMACEUTICAL COMPOSITIONS CONTAINING BORATE-POLYOL COMPLEXES | 2009 |
|
RU2477631C2 |
| SOLID PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION AND METHOD FOR ITS PREPARING | 2002 |
|
RU2234915C2 |
| COMPOSITION FOR PREVENTING OR TREATING PROCTOLOGICAL DISEASES | 2022 |
|
RU2814279C2 |
| METHODS AND COMPOSITIONS FOR TREATING DRY EYE | 2008 |
|
RU2470662C2 |
| USING LEVOFLOXACIN IN AEROSOL FORM FOR TREATING MUCOVISCIDOSIS | 2010 |
|
RU2563809C2 |
